Tapering Duloxetine and Initiating Bupropion
Taper duloxetine 60 mg down to 30 mg daily for at least 1-2 weeks before discontinuation to minimize withdrawal symptoms, then start bupropion 150 mg once daily in the morning after stopping duloxetine 1, 2.
Duloxetine Discontinuation Strategy
SNRIs like duloxetine require slow tapering to prevent discontinuation syndrome 1. The evidence consistently emphasizes that abrupt discontinuation of SNRIs can precipitate withdrawal symptoms including:
- Dizziness, headache, nausea
- Paresthesias (electric shock sensations)
- Anxiety, irritability, agitation
- Insomnia or vivid dreams
- Flu-like symptoms
Recommended Taper Schedule
From your current dose of 60 mg daily:
- Reduce to 30 mg once daily for 1-2 weeks minimum 3
- Then discontinue completely
The evidence shows that duloxetine has a sufficiently long elimination half-life to permit once-daily dosing 1, but this also means withdrawal symptoms can emerge when stopping. Research demonstrates that starting doses and titration significantly impact tolerability - slower tapers with lower intermediate doses reduce discontinuation rates due to adverse events 4.
Critical caveat: Recent research strongly warns against alternate-day dosing strategies when tapering 5. Dosing every other day causes pronounced receptor occupancy variation and likely increases withdrawal symptoms - this approach cannot be recommended.
For patients at higher risk of withdrawal (longer duration of therapy, previous difficulty stopping antidepressants), consider an even slower taper over several weeks using 30 mg for 2-4 weeks before stopping 6.
Initiating Bupropion
Start bupropion 150 mg once daily in the morning after completing the duloxetine taper 2. The FDA-approved dosing is:
- Days 1-4: 150 mg once daily in the morning
- After day 4: May increase to 300 mg once daily if needed 2
Key Safety Considerations
Swallow tablets whole - do not crush, divide, or chew 2. This is critical for the extended-release formulation to work properly and minimize seizure risk.
Monitor for neuropsychiatric symptoms including depression worsening, suicidal ideation, agitation, or behavioral changes, particularly in the first 1-2 weeks 7, 8. While uncommon, these warrant immediate discontinuation if they occur.
Contraindications to assess before starting bupropion 7:
- Seizure disorder or conditions increasing seizure risk (stroke, brain metastases, eating disorders)
- Current MAOI use (requires 14-day washout period)
- Closed-angle glaucoma
Timing Between Medications
You can start bupropion immediately after stopping duloxetine - there is no required washout period between these two medications as they have different mechanisms of action and no dangerous interactions 2. The 14-day washout requirement only applies when switching to/from MAOIs 2.
Monitoring During Transition
Assess patient status within 1-2 weeks of starting bupropion 8. Monitor for:
- Emergence of withdrawal symptoms from duloxetine (if present, may need to slow taper further)
- Treatment response to bupropion
- Adverse effects (insomnia, agitation, nausea)
- Blood pressure (bupropion can increase BP in some patients)
- Suicidal ideation or behavioral changes
If inadequate response after 6-8 weeks on bupropion, modify treatment 8. This may include increasing to 300 mg daily or considering alternative strategies.
Clinical Context
The combination of duloxetine and bupropion has been studied in treatment-resistant depression 9, but your question indicates a switch rather than combination therapy. Research comparing these agents in adolescent females showed bupropion may have advantages in reducing depressive symptoms with lower suicide attempt rates compared to duloxetine 10, though this was in a specific population.
The gradual taper approach prioritizes minimizing withdrawal-related morbidity while safely transitioning to the new medication.